When can I buy generic Wegovy in India from Sun Pharma?

Generic Wegovy, under the brand name Noveltreat, is expected to launch in India after the semaglutide patent expires in March 2026.

What is Sun Pharma's generic weight-loss drug called?

Sun Pharma's generic version of Wegovy will be launched in India under the brand name Noveltreat.

Who else is entering the generic Ozempic/Wegovy market in India?

Dr Reddy's Laboratories has also received approval to manufacture and sell the generic version of Ozempic, indicating significant competition.

Home / Business and Economy / Generic Wegovy Approval Sparks Indian Race

Generic Wegovy Approval Sparks Indian Race

23 Jan

•

Summary

Sun Pharma gets approval to sell generic Wegovy in India.
Generic semaglutide to launch under Noveltreat brand.
Patent expiry in March 2026 spurs market entry race.

Generic Wegovy Approval Sparks Indian Race

Sun Pharmaceutical Industries, India's largest drugmaker by revenue, announced on Friday, January 23, 2026, that it has secured regulatory approval to produce and market the generic version of the popular weight-loss medication Wegovy within the country.

The generic form of semaglutide, the key ingredient in Novo Nordisk's Wegovy and Ozempic, will be introduced in India under the brand name Noveltreat. This launch is scheduled to occur after the semaglutide patent concludes in March 2026.

This development highlights a competitive race among Indian generic drug manufacturers to capture a significant share of the rapidly expanding weight-loss drug market. Sun Pharma's approval follows closely behind Dr Reddy's Laboratories, which announced earlier this week a similar nod for the generic version of Ozempic.